title: ITPA genotyping test does not improve detection of Crohn's disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression.
authors.forename: D
authors.initials: D
authors.lastname: Allorge
authors.forename: R
authors.initials: R
authors.lastname: Hamdan
authors.forename: F
authors.initials: F
authors.lastname: Broly
authors.forename: C
authors.initials: C
authors.lastname: Libersa
authors.forename: J-F
authors.initials: JF
authors.lastname: Colombel
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001379:Azathioprine / Q000009:adverse effects*; D003424:Crohn Disease / Q000235:genetics*; D004359:Drug Therapy, Combination; D020022:Genetic Predisposition to Disease; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007970:Leukopenia / Q000139:chemically induced; D015122:Mercaptopurine / Q000009:adverse effects*; D011755:Pyrophosphatases / Q000235:genetics*; D000097630:Inosine Triphosphatase
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001379:Azathioprine; D007166:Immunosuppressive Agents; D015122:Mercaptopurine; D011755:Pyrophosphatases; D000097630:Inosine Triphosphatase